ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
Dow Jones
44,296.51
0.97%
Brent Oil
74.65
0.00%
Bitcoin
98,559.18
-0.48%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Biora Therapeutics Inc (BIOR) Quote

Biora Therapeutics Inc

Biora Therapeutics Inc (BIOR)

NASDAQ
1.67
0.04
(2.45%)
Closed November 23 4:00PM
Delayed by 15 minutes
1.62
-0.05
(-2.99%)
After Hours: 7:59PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.67
Bid
1.58
Ask
1.67
Volume
82,438
1.56 Day's Range 1.69
1.43 52 Week Range 19.90
Market Cap
6.142M
Previous Close
1.63
Open
1.62
Last Trade
45
@
1.5801
Last Trade Time
Financial Volume
$ 135,142
VWAP
1.6393
Average Volume (3m)
186,781
Shares Outstanding
3,677,747
Dividend Yield
-
PE Ratio
-0.05
Earnings Per Share (EPS)
-33.75
Revenue
4k
Net Profit
-124.12M

About Biora Therapeutics Inc

Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.bicara.com
Headquarters
Dover, Delaware, USA
Founded
-
Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $1.63. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 1.43 to $ 19.90.

Biora Therapeutics currently has 3,677,747 shares outstanding. The market capitalization of Biora Therapeutics is $5.99 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.05.

Ask ADVFN Intelligence (AI)

BIOR Latest News

More News

Form 8-K - Current report

November 15 2024
Edgar (US Regulatory)

Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain...

November 14 2024
GlobeNewswire Inc.

Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update

SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and...

November 07 2024
GlobeNewswire Inc.

Form 8-K - Current report

October 29 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

October 29 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

October 29 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

October 29 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

October 29 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

October 29 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

October 29 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.8-32.38866396762.472.51.431624711.77751066CS
4-1.9-53.22128851543.574.421.431315292.66338235CS
12-5.42-76.44569816647.097.11.431867814.91143724CS
26-5.33-76.142857142977.91.432142685.86343342CS
52-12.03-87.810218978113.719.91.433710249.66732228CS
156-213.33-99.223255814215287.51.4385811997.64633531CS
260-213.33-99.223255814215287.51.4385811997.64633531CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
$ 8.26
(89.02%)
2.03M
XCURExicure Inc
$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
$ 0.0201
(-0.50%)
415.87M
NVDANVIDIA Corporation
$ 141.95
(-3.22%)
229.93M
SMCISuper Micro Computer Inc
$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
$ 0.5501
(-6.72%)
154.17M
SOUNSoundHound AI Inc
$ 8.24
(18.05%)
103.6M

BIOR Discussion

View Posts
Monksdream Monksdream 3 weeks ago
BIOR, new 52 week low
👍️0
Monksdream Monksdream 3 weeks ago
BIOR, new 52 week low
👍️0
The Night Stalker The Night Stalker 6 months ago
nice
👍️0
Arnold25764 Arnold25764 7 months ago
Any possible catalyst here?
👍️0
Monksdream Monksdream 7 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 8 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 8 months ago
BIOR 10Q due 3/26
👍️0
Monksdream Monksdream 8 months ago
BIOR under $2
👍️0
glenn1919 glenn1919 9 months ago
BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 9 months ago
BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 12 months ago
BIOR new 52 week low
👍️0
Monksdream Monksdream 12 months ago
BOIR new 52 week low
👍️0
Monksdream Monksdream 12 months ago
BIOR new 52 week low
👍️0
TheFinalCD TheFinalCD 12 months ago
https://finviz.com/quote.ashx?t=BIOR&p=d

https://dilutiontracker.com/app/search/BIOR
👍️0
Awl416 Awl416 12 months ago
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
👍️0
retireat40 retireat40 1 year ago
Looked good this morning at 2.66 but a crappy close.
👍️0
Monksdream Monksdream 1 year ago
BIOR Barchart Bottom 100
Biora Therapeutics Inc NASDAQ: BIOR



GoSymbol lookup
Health Care : Biotechnology | Small Cap ValueCompany profile
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
👍️0

Your Recent History

NASDAQ
BIOR
Biora Therapeutics
DOWI
DWCCHC
DJ US Commodity Chemical...
LSE
TUN
Tungsten West
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved